Market Overview

UPDATE: Deutsche Bank Raises PT on Medtronic Following F1Q14 Sales Results


In a report published Thursday, Deutsche Bank analyst Greg Poole reiterated a Hold rating on Medtronic (NYSE: MDT), and raised the price target from $55.00 to $56.00.

In the report, Deutsche Bank noted, “Medtronic's F1Q14 sales were just below the Street estimates while EPS was in line. However, of greater interest to us was management's commentary on the quarterly call regarding its strategy of transforming from a device provider to a global medical technology solutions partner. While we wouldn't disagree that this is a good strategic move, albeit not one without risks, we see it as further evidence of the evolving landscape and more challenging outlook for MedTech. We maintain our Hold rating.”

Medtronic closed on Wednesday at $52.68.

Latest Ratings for MDT

Jun 2019UpgradesMarket PerformOutperform
Apr 2019MaintainsMarket PerformMarket Perform
Feb 2019MaintainsNeutralNeutral

View More Analyst Ratings for MDT
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Greg PooleAnalyst Color Price Target Analyst Ratings


Related Articles (MDT)

View Comments and Join the Discussion!

UPDATE: BMO Capital Raises PT on Lowe's Companies Following 2Q13 EPS Release

UPDATE: Deutsche Bank Lowers PT on Coach on Mixed Factors